γ-glutamyl transferase-to-platelet ratio based nomogram predicting overall survival of gallbladder carcinoma

Abstract

BACKGROUND Gallbladder carcinoma (GBC) carries a poor prognosis and requires a prediction method. Gamma-glutamyl transferase–to–platelet ratio (GPR) is a recently reported cancer prognostic factor. Although the mechanism for the relationship between GPR and poor cancer prognosis remains unclear, studies have demonstrated the clinical effect of both gamma-glutamyl transferase and platelet count on GBC and related gallbladder diseases. AIM To assess the prognostic value of GPR and to design a prognostic nomogram for GBC. METHODS The analysis involved 130 GBC patients who underwent surgery at Peking Union Medical College Hospital from December 2003 to April 2017. The patients were stratified into a high- or low-GPR group. The predictive ability of GPR was evaluated by Kaplan–Meier analysis and a Cox regression model. We developed a nomogram based on GPR, which we verified using calibration curves. The nomogram and other prognosis prediction models were compared using time-dependent receiver operating characteristic curves and the concordance index. RESULTS Patients in the high-GPR group had a higher risk of jaundice, were older, and had higher carbohydrate antigen 19-9 levels and worse postoperative outcomes. Univariate analysis revealed that GPR, age, body mass index, tumor–node–metastasis (TNM) stage, jaundice, cancer cell differentiation degree, and carcinoembryonic antigen and carbohydrate antigen 19-9 levels were related to overall survival (OS). Multivariate analysis confirmed that GPR, body mass index, age, and TNM stage were independent predictors of poor OS. Calibration curves were highly consistent with actual observations. Comparisons of time-dependent receiver operating characteristic curves and the concordance index showed advantages for the nomogram over TNM staging. CONCLUSION GPR is an independent predictor of GBC prognosis, and nomogram-integrated GPR is a promising predictive model for OS in GBC.

Prognostic impact of gamma-glutamyl transpeptidase to platelets ratio on hepatocellular carcinoma patients who have undergone surgery: a meta-analysis and systematic review

“…A recent study has revealed that a high GPR is associated with poor survival of patients with cancer [40]. Our meta-analysis of 10 studies including 4706 patients also found that HCC patients with high GPR had shorter OS, RFS, and DFS than those with low GPR.…”

Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids

“…The risk factors for eCCA include primary sclerosing cholangitis, smoking, and heavy alcohol drinking [ 2 , 3 ]. In contrast, GBC is one of the most common malignancies of the digestive system, accounting for approximately 1% of all cancers and 80–95% of all eBTCs [ 4 ]. The main causes of GBC are gallstones and chronic cholecystitis and can therefore easily be confused with them due to similar symptoms [ 5 ].…”

New trends in diagnosis and management of gallbladder carcinoma

“…Revealing residual disease in the specimen of the second operation after incidental discovery of GB carcinoma with cholecystectomy predicts worse prognosis, despite the achievement of R0 resection[ 160 ]. The ratio of γ-glutamyl transferase to platelet count may predict GB carcinoma patient survival and was included in a relevant nomogram[ 161 ]. There are several prognostic scoring systems and nomograms predicting survival[ 162 - 166 ] or lymph node metastases[ 167 ].…”